Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Research and development | 4M | 6M | 4M | 4M | 3M | 3M |
| Selling, general and administrative | 2M | 2M | 3M | 2M | 2M | 2M |
| Operating income | −6M | −8M | −7M | −6M | −4M | −5M |
| Net income | −6M | −7M | −6M | −5M | −4M | −4M |
| Earnings per share | −0.26 | −0.44 | −0.30 | −0.27 | −0.24 | −0.26 |
| Earnings per share, diluted | −0.26 | −0.44 | −0.30 | −0.27 | −0.24 | −0.26 |
| Weighted average shares | 23M | 23M | 21M | 20M | 17M | 17M |
| Weighted average shares, diluted | 23M | 23M | 21M | 20M | 17M | 17M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 25M | 32M | 35M | 27M | 30M | 19M | 17M | 18M |
| Current assets | 25M | 32M | 36M |
| Metric | 31/03/2026 | 31/03/2025 |
|---|---|---|
| Operating cash flow | −7M | −4M |
| Share-based compensation | 2M | 1M |
| Investing cash flow | 0 | 0 |
| Financing cash flow | 7,000 | 16M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 27M |
| 30M |
| 19M |
| 17M |
| 18M |
| Total assets | 25M | 32M | 36M | 27M | 30M | 19M | 17M | 18M |
| Current liabilities | 11M | 13M | 12M | 10M | 9M | 9M | 6M | 6M |
| Total liabilities | 11M | 13M | 12M | 10M | 9M | 9M | 6M | 6M |
| Equity | 14M | 18M | 24M | 17M | 21M | 10M | 11M | 13M |
| Shares outstanding | 27M | 26M | 26M | 24M | 24M | 19M | 19M | 19M |
| Shares issued | 27M | 26M | 26M | 24M | 24M | 19M | 19M | 19M |